Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572450

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue	—	786,946,000,000 JPY	—	—	—	—	—	—	—	—	686,184,000,000 JPY	—	—	—
Cost of sales	—	273,465,000,000 JPY	—	—	—	—	—	—	—	—	266,071,000,000 JPY	—	—	—
Gross profit	—	513,481,000,000 JPY	—	—	—	—	—	—	—	—	420,113,000,000 JPY	—	—	—
Other expenses	—	1,504,000,000 JPY	—	—	—	—	—	—	—	—	3,124,000,000 JPY	—	—	—
Operating profit (loss)	—	301,230,000,000 JPY	—	—	—	—	—	—	—	—	210,597,000,000 JPY	—	—	—
Finance costs	—	62,000,000 JPY	—	—	—	—	—	—	—	—	125,000,000 JPY	—	—	—
Profit (loss) before tax	—	298,188,000,000 JPY	—	—	—	—	—	—	—	—	207,893,000,000 JPY	—	—	—
Income tax expense	—	83,455,000,000 JPY	—	—	—	—	—	—	—	—	50,333,000,000 JPY	—	—	—
Profit (loss)	JPY	214,733,000,000 JPY	214,733,000,000 JPY	JPY	JPY	JPY	214,733,000,000 JPY	JPY	JPY	157,560,000,000 JPY	157,560,000,000 JPY	JPY	157,560,000,000 JPY	JPY
Profit (loss) attributable to
Owners of parent	—	214,733,000,000 JPY	—	—	—	—	—	—	—	—	157,560,000,000 JPY	—	—	—
Earnings (loss) per share
Basic earnings (loss) per share	—	130.66	—	—	—	—	—	—	—	—	95.95	—	—	—
Diluted earnings (loss) per share	—	130.53	—	—	—	—	—	—	—	—	95.81	—	—	—